Effectiveness and Safety of Upadacitinib in Adults Older Than 50 Years With Moderate‐To‐Severe Atopic Dermatitis: A Multicenter Study

Francisco Javier Melgosa Ramos has received honoraria and/or travel grants and/or has acted as an advisory board member for Novartis, Abbvie, Janssen Cilag, UCB, Lilly, LEO Pharma, L'Oreal, Sanofi, Almirall, and Amgen. Lorena Vila Cobreros, Marta Galarreta Pascual, Santiago Guillén Climent, María Matellanes Palacios, Juncal Roca Ginés, Javier Sabater Abad, Eduardo Bernia Petit, Andrés Casanova Esquembre, Andrea Estébanez Corrales, and Carlos Abril Pérez declare no conflicts of interest regarding this manuscript. Victor González Delgado has received honoraria and/or travel grants and/or has acted as an advisory board member for Abbvie, Janssen Cilag, Lilly, LEO Pharma, Pfizer, Sanofi, Almirall, and Amgen. The other authors have no conflicts of interest to declare. All data are available upon request from the authors.

Authors

Institutions

Publication Details

Journal
International Journal of Dermatology
Published
2025-04-16
DOI
https://doi.org/10.1111/ijd.17797
Citations
1
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
2.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effectiveness and Safety of Upadacitinib in Adults Older Than 50 Years With Moderate‐To‐Severe Atopic Dermatitis: A Multicenter Study

Javier Sabater‐Abad, María Matellanes‐Palacios, Santiago Guillén‐Climent, Juncal Roca Ginés et al.
1 citations
International Journal of Dermatology
Dermatology and Skin Diseases
2.00
article

Effectiveness and Safety of Upadacitinib in Adults Older Than 50 Years With Moderate‐To‐Severe Atopic Dermatitis: A Multicenter Study

Javier Sabater‐Abad, María Matellanes‐Palacios, Santiago Guillén‐Climent, Juncal Roca Ginés, Carlos Abril‐Pérez, Francisco Javier Melgosa Ramos, Andrés Casanova Esquembre, Andrea Estébanez Corrales, Lorena Vila Cobreros, Marta Galarreta Pascual, V.A. González-Delgado, Eduardo Bernia‐Petit
article en
1 citations

Abstract

Francisco Javier Melgosa Ramos has received honoraria and/or travel grants and/or has acted as an advisory board member for Novartis, Abbvie, Janssen Cilag, UCB, Lilly, LEO Pharma, L'Oreal, Sanofi, Almirall, and Amgen. Lorena Vila Cobreros, Marta Galarreta Pascual, Santiago Guillén Climent, María Matellanes Palacios, Juncal Roca Ginés, Javier Sabater Abad, Eduardo Bernia Petit, Andrés Casanova Esquembre, Andrea Estébanez Corrales, and Carlos Abril Pérez declare no conflicts of interest regarding this manuscript. Victor González Delgado has received honoraria and/or travel grants and/or has acted as an advisory board member for Abbvie, Janssen Cilag, Lilly, LEO Pharma, Pfizer, Sanofi, Almirall, and Amgen. The other authors have no conflicts of interest to declare. All data are available upon request from the authors.

International Journal of DermatologyVol. 65(1)
Hospital Universitari i Politècnic La Fe (ES), Hospital de La Ribera (ES), Hospital Clínico Universitario de Valencia (ES), Hospital Arnau de Vilanova (ES), Hospital Universitario Doctor Peset (ES), Hospital General Universitario De Valencia (ES), Hospital Universitario Lluís Alcanyís (ES), Hospital Virgen de los Lirios (ES)
Openalex Percentile: Top 16%
Dermatology and Skin Diseases
2.00
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.